The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

((SL Advertiser)) V-Juv offers up a simple solution for men and women who suffer from incontinence. No more diapers! call ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Imbrium Therapeutics L.P. ("Imbrium"), a subsidiary of Purdue Pharma L.P. ("Purdue"), announced results from a Phase 1b clinical signal detection study evaluating the safety and efficacy of the novel ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) symptoms ...

OAB can significantly impact quality of life; it can impact physical functioning, sexual function and social interactions. The standard treatments for overactive bladder include lifestyle changes ...

for the treatment of overactive bladder (OAB).This is the first time that CTAF has addressed this topic.

Despite medical advances and increased awareness campaigns, many men continue postponing essential prostate treatment. Health care providers identify several key factors contributing to these ...

Consult a doctor as some treatment types suited for men may not be suitable for women and vice versa. Topical Solutions for Different Types of Hair Loss Different types of hair loss require ...

Movember aims to raise awareness of men’s health for the month of November. Prostate cancer is the most common (non-cutaneous ...

Brooke Shields is standing up for what's right. In her new memoir Brooke Shields Is Not Allowed to Get Old, the 59-year-old ...